Among those with stock price declines were Bristol-Myers Squibb …
stock prices
Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company Description: Johnson & Johnson is a leader in the pharmaceutical, medical …
Johnson & Johnson
Johnson & Johnson Inc. (NYSE: JNJ) is a worldwide leader in pharmaceuticals, medical devices and consumer health care products. Based in New Brunswick, New Jersey, Johnson & Johnson has over 250 operating …
Johnson & Johnson
Still, though, I doubt very many people who owned Abbott stock back in 2011 and 2012 are disappointed now that the company spun off AbbVie. …
Johnson Johnson
Of the 11 S&P 500 sectors, technology leads followed by gain from …
Johnson & Johnson
Johnson & Johnson (NYSE:JNJ) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday. According to Zacks, “J&J’s Pharma segment is …
BNS14d
Johnson & Johnson
Johnson & Johnson on 10/18/2016 reported its EPS as $1.68 with the analysts projecting the EPS of the stock as $1.66. The company had revenue of $17.80 billion for the quarter, compared to the consensus estimate of …
Johnson Johnson
What about 2017? Here are seven reasons Gonzalez highlighted that could propel AbbVie's stock higher this year. There are several potential …
AbbVie